Sanjay Malhotra

Sanjay Malhotra is a Professor of Cell, Developmental and Cancer Biology at Oregon Health & Science University, where he holds the Sheila Edwards-Lienhart Chair in Cancer Research and directs the Centers for Experimental Therapeutics and Radiochemistry Research. His research focuses on cancer pharmacology, tumor biology, and therapeutic target identification, with recent work emphasizing indole-derived non-orthosteric inhibitors of PIM-1 kinase, exosome-mediated drug resistance in breast cancer, and novel anticancer sulfonamides and minor groove binders. His latest publications include studies on combination therapies to improve immune checkpoint blockade efficacy and the design of alkyne-linked thiazole anticancer agents. His work bridges medicinal chemistry and translational oncology, advancing targeted cancer treatment strategies.